Emergent BioSolutions
EBS
#7508
Rank
C$0.59 B
Marketcap
C$11.51
Share price
2.92%
Change (1 day)
69.24%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): C$0.23 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are C$0.75 Billion. In 2024 the company made an earning of -C$97.7 Million, an increase over its 2023 earnings that were of -C$0.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.23 B-340.22%
2024 -C$97.7 Million-88.82%
2023 -C$0.88 Billion242.73%
2022 -C$0.26 Billion-153.8%
2021 C$0.47 B-20.43%
2020 C$0.59 B278.02%
2019 C$0.15 B27.11%
2018 C$0.12 B-27.12%
2017 C$0.17 B17.21%
2016 C$0.14 B0.45%
2015 C$0.14 B73.51%
2014 C$83.29 M41.36%
2013 C$58.92 M35.2%
2012 C$43.58 M0.4%
2011 C$43.41 M-56.46%
2010 C$99.69 M76.73%
2009 C$56.41 M32.94%
2008 C$42.43 M-5.62%
2007 C$44.96 M
2005 C$65.1 M269.89%
2004 C$17.6 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$13.84 B 6,065.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$30.46 B 13,465.03%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.44 B 5,886.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-C$16.81 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
C$0.12 B-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.4 Billion-273.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.92 B 1,201.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel